ReviewFrontiers in oncology2026

Integrating chemokine signatures and multi-omic biomarkers to predict immunotherapy response in non-small cell lung cancer: a comprehensive narrative review.

Luis Cabezón-Gutiérrez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.